Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Han-Chung Hsiue

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Trials (London, England)|March 3, 2020
Estimated costs of pivotal trials for U.S. Food and Drug Administration-approved cancer drugs, 2015-2017Emily Han-Chung Hsiue, Thomas J Moore, G Caleb Alexander
Cancer Treatment Reviews|July 22, 2019
Opportunities of circulating tumor DNA in lung cancerTing-Hui Wu, Emily Han-Chung Hsiue, James Chih-Hsin Yang
Expert Review of Molecular Diagnostics|October 15, 2016
Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancerEmily Han-Chung Hsiue, Jih-Hsiang Lee, Chia-Chi Lin, et al.
Expert Opinion on Drug Safety|May 24, 2016
Safety of gefitinib in non-small cell lung cancer treatmentEmily Han-Chung Hsiue, Jih-Hsiang Lee, Chia-Chi Lin, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 31, 2017
Epithelioid Trophoblastic Tumor Around an Abdominal Cesarean Scar: A Pathologic and Molecular Genetic AnalysisEmily Han-Chung Hsiue, Chiun Hsu, Li-Hui Tseng, et al.
Expert Review of Respiratory Medicine|December 9, 2016
New data on clinical decisions in NSCLC patients with uncommon EGFR mutationsTing-Hui Wu, Emily Han-Chung Hsiue, Jih-Hsiang Lee, et al.
The Oncologist|April 15, 2017
National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer PatientsYu-Yun Shao, Emily Han-Chung Hsiue, Chih-Hung Hsu, et al.
Cancers|March 10, 2022
Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical SamplesYuri Laguna Terai, Chun Huang, Baoli Wang, et al.
Cancer Immunology Research|September 19, 2019
Direct Detection and Quantification of NeoantigensQing Wang, Jacqueline Douglass, Michael S Hwang, et al.
Clinical Lung Cancer|February 26, 2018
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer PatientsTing-Hui Wu, Emily Han-Chung Hsiue, Jih-Hsiang Lee, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Trials (London, England)|March 3, 2020
Estimated costs of pivotal trials for U.S. Food and Drug Administration-approved cancer drugs, 2015-2017Emily Han-Chung Hsiue, Thomas J Moore, G Caleb Alexander
Cancer Treatment Reviews|July 22, 2019
Opportunities of circulating tumor DNA in lung cancerTing-Hui Wu, Emily Han-Chung Hsiue, James Chih-Hsin Yang
Expert Review of Molecular Diagnostics|October 15, 2016
Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancerEmily Han-Chung Hsiue, Jih-Hsiang Lee, Chia-Chi Lin, et al.
Expert Opinion on Drug Safety|May 24, 2016
Safety of gefitinib in non-small cell lung cancer treatmentEmily Han-Chung Hsiue, Jih-Hsiang Lee, Chia-Chi Lin, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 31, 2017
Epithelioid Trophoblastic Tumor Around an Abdominal Cesarean Scar: A Pathologic and Molecular Genetic AnalysisEmily Han-Chung Hsiue, Chiun Hsu, Li-Hui Tseng, et al.
Expert Review of Respiratory Medicine|December 9, 2016
New data on clinical decisions in NSCLC patients with uncommon EGFR mutationsTing-Hui Wu, Emily Han-Chung Hsiue, Jih-Hsiang Lee, et al.
The Oncologist|April 15, 2017
National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer PatientsYu-Yun Shao, Emily Han-Chung Hsiue, Chih-Hung Hsu, et al.
Cancers|March 10, 2022
Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical SamplesYuri Laguna Terai, Chun Huang, Baoli Wang, et al.
Cancer Immunology Research|September 19, 2019
Direct Detection and Quantification of NeoantigensQing Wang, Jacqueline Douglass, Michael S Hwang, et al.
Clinical Lung Cancer|February 26, 2018
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer PatientsTing-Hui Wu, Emily Han-Chung Hsiue, Jih-Hsiang Lee, et al.
Pageof 3